Dreamm-6: Safety And Tolerability Of Belantamab Mafodotin In Combination With Bortezomib/Dexamethasone In Relapsed/Refractory Multiple Myeloma (Rrmm).

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 41|浏览30
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要